Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
State Street SPDR S&P Biotech ETF
(NY:
XBI
)
119.59
-4.31 (-3.48%)
Official Closing Price
Updated: 8:00 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,706,312
Open
123.24
Bid (Size)
119.02 (100)
Ask (Size)
119.48 (2,000)
Prev. Close
123.90
Today's Range
119.51 - 123.69
52wk Range
66.66 - 132.09
Shares Outstanding
541,500
Dividend Yield
1.36%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Small Caps Under Siege: Russell 2000 Enters Correction as Yields Surge
March 23, 2026
The small-cap segment of the U.S. stock market has officially entered correction territory, marking a stark reversal for a sector that many analysts expected to lead the "Great Rotation" of 2026. On...
Via
MarketMinute
Topics
Bonds
ETFs
Economy
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
↗
March 21, 2026
iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names. That structure can offer more earnings visibility, but...
Via
The Motley Fool
Topics
Derivatives
ETFs
Regulatory Compliance
Performance
YTD
-1.6%
-1.6%
1 Month
-6.3%
-6.3%
3 Month
-3.1%
-3.1%
6 Month
+20.3%
+20.3%
1 Year
+41.7%
+41.7%
More News
Read More
IBRX Stock Rises Overnight: Retail Bets Anktiva’s NCCN 'Recommended' Tag Will Drive Prescriptions And Insurance Wins
↗
March 17, 2026
Via
Stocktwits
Topics
ETFs
The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)
March 12, 2026
Via
Finterra
Topics
ETFs
Intellectual Property
Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest?
↗
March 11, 2026
Via
Stocktwits
Topics
ETFs
QURE Stock Edges Up After Hours As Analyst Flags Reduced Regulatory Uncertainty Following Prasad’s FDA Exit
↗
March 10, 2026
Via
Stocktwits
QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure
↗
March 10, 2026
Via
Stocktwits
Topics
Initial Public Offering
QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150
↗
March 09, 2026
Via
Stocktwits
IBRX Stock Declines Pre-Market — ImmunityBio Resubmits Anktiva Application To FDA With Additional Data
↗
March 09, 2026
Via
Stocktwits
ALT Stock Drops On Wider-Than-Expected Q4 Loss: Retail Voices Hopes For Deal To Alleviate Cash Concerns
↗
March 05, 2026
Via
Stocktwits
Why Did CRMD Stock Tumble Over 11% Today?
↗
March 05, 2026
Via
Stocktwits
Topics
Artificial Intelligence
Why Did BTAI Stock Surge 20% In Pre-Market Today?
↗
March 05, 2026
Via
Stocktwits
Liquidia Stock Gains Premarket On Q4 Revenue Beat – Investors Are Betting On YUTREPIA Growth
↗
March 05, 2026
Via
Stocktwits
Topics
Artificial Intelligence
DAWN Shares Rally On Buyout Speculation But Retail Warns A Deal Might Not Materialise
↗
March 04, 2026
Via
Stocktwits
Topics
Economy
IBRX Stock Drops On Investor Concerns Over Immunotherapy Launch In Saudi Arabia Amid Middle East Tensions But Analyst Sees 20% Upside
↗
March 04, 2026
Via
Stocktwits
Topics
Intellectual Property
Why Did NTLA Stock Jump 10% In Pre-Market Today?
↗
March 02, 2026
Via
Stocktwits
Why Did QURE Stock Almost Halve Pre-Market Today?
↗
March 02, 2026
Via
Stocktwits
AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction
↗
February 26, 2026
Via
Stocktwits
IBRX Stock Rises Pre-Market After ANKTIVA Combo Shows Stronger Bladder Cancer Responses In Phase 2 Trial
↗
February 26, 2026
Via
Stocktwits
CLDX Soars On Bullish Timelines For Urticaria Clinical Program: Retail Sees Experimental Skin Treatment’s Sales Beat Big Pharma’s Dupixent
↗
February 25, 2026
Via
Stocktwits
Topics
Earnings
RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’
↗
February 25, 2026
Via
Stocktwits
Topics
Artificial Intelligence
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts
↗
February 24, 2026
Via
Stocktwits
Topics
Artificial Intelligence
Earnings
Why Did PVLA Stock Surge 45% In Pre-Market Today?
↗
February 24, 2026
Via
Stocktwits
RARE Stock Edges Up On Priority Review For Gene Therapy In Rare Metabolic Disorder
↗
February 23, 2026
Via
Stocktwits
ImmunityBio Inks Partnerships To Launch Cancer Drug In Saudi Arabia Amid Expansion Efforts
↗
February 20, 2026
Via
Stocktwits
Frequently Asked Questions
Is State Street SPDR S&P Biotech ETF publicly traded?
Yes, State Street SPDR S&P Biotech ETF is publicly traded.
What exchange does State Street SPDR S&P Biotech ETF trade on?
State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Biotech ETF?
The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of State Street SPDR S&P Biotech ETF?
The current price of State Street SPDR S&P Biotech ETF is 119.59
When was State Street SPDR S&P Biotech ETF last traded?
The last trade of State Street SPDR S&P Biotech ETF was at 03/27/26 08:00 PM ET
What is the market capitalization of State Street SPDR S&P Biotech ETF?
The market capitalization of State Street SPDR S&P Biotech ETF is 64.76M
How many shares of State Street SPDR S&P Biotech ETF are outstanding?
State Street SPDR S&P Biotech ETF has 65M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.